Alliance Healthcare backs campaign to bring vital medicines to Ukraine
Alliance Healthcare UK aids in the camapign for support for the Medicines to Ukraine initiative, which aims to supply hospitals in the war-torn country with the vital medicines they need to treat casualties from the conflict.
Following the start of the devastating war in Ukraine, countries all over the world have tried to show their support and send aid for the people of Ukraine.
The Medicines to Ukraine Campaign is a cross-European campaign started by Employed Pharmacists in Europe (EPhEU). The campaign seeks to source medicines from donations and get them to the casualties in hospitals, overcoming challenges such as proper quality control and transport and distribution issues.
In the UK, the Medicines to Ukraine pharmacy appeal is led by The Healthcare Distribution Association (HDA),
Pharmacists' Defence Association (PDA), and National Pharmacy Association (NPA). The appeal asks pharmacy teams to advocate for the campaign and encourage customers and the general public to donate to support the charity’s work.
Alliance Healthcare UK, as one of the country’s largest pharmaceutical wholesalers, is a key supporter of the Medicine to Ukraine Campaign. Alliance Healthcare UK has brought attention to the campaign via their wide distribution network and extensive communication capabilities, including a UK-wide poster drop to pharmacies of 15,000 posters.
The campaign obtains specialist medicines that are needed by Ukrainian hospitals that are running on depleted or non-existent stores, but still desperately trying to treat the casualties of war.
In the UK, £220,000 has been raised so far through the appeal, with a total of £3 million raised across all of Europe so far.
Martin Sawer, Executive Director of HDA commented:
“Our member companies’ distribution networks ensure a comprehensive, resilient and efficient supply system is always there for community pharmacies, hospitals, and dispensing doctors. The Association is delighted that an HDA distributor is making use of its own intensive national network to enable this vital campaign.”
Matt Addison, Operations Director at Alliance Healthcare, stated:
“Each of the 16,500 pharmacies that we supply each day will play an important role in raising awareness of the Medicines to Ukraine campaign. Alliance Healthcare is fortunate to have an operation ready to help our pharmacy customers activate this important appeal and play its part to help those impacted by the war in Ukraine.”
Source: Alliance Healthcare. Alliance Healthcare UK Supports Medicines to Ukraine Campaign. [Date accessed 25/05/2023]
Related News
-
News How to disrupt an industry as big as pharma for the better?
In this interview, hear from Matthew Wise, Head of Data at CCD Partners, on the companies they've been looking into that are offering new and interesting perspectives that have the potential to shake up the pharmaceutical industry, and how they'... -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance